Dr. Buchsbaum is an Associate Professor, Indiana University School of Medicine, Departments of Radiation Oncology, Pediatrics, and Neurological Surgery, IU Health University Hospital, IU Health Proton Therapy Center, Bloomington, IN.
Dr. Vogel is an assistant professor, Department of Radiation Oncology,Vanderbilt University Medical Center, Nashville, TN. Dr. Venigalla is an instructor, Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia. Dr. Sharma is an assistant professor, Department of Radiation Oncology, Mt. Sinai Hospital, New York, NY. Dr. Lustig is a professor, Dr. Hill-Kayser is an associate professor, and Dr. Shabason is an assistant professor, Department of Radiation Oncology, Hospital of the University of Pennsylvania. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript. Prior presentation: This manuscript was presented in abstract form at the American Society for Radiation Oncology 2018 meeting in San Antonio, Texas, Oct. 21-24.
Dr. Chan is a medical resident at The Ottawa Hospital and the University of Ottawa, Canada; a PhD student at Amsterdam UMC – Vrije University Medical Center, The Netherlands; and a former intern at the International Atomic Energy Agency (IAEA), Vienna, Austria. Dr. Polo, Dr. Zubizarreta and Dr. Abdel-Wahab are radiation oncologists at IAEA. Dr. Bourque is a radiation oncologist at The Ottawa Hospital and the University of Ottawa; a consultant at IAEA; and a research affiliate at the Institute of Cancer Policy, Kings College London, United Kingdom. Dr. Dennis is a radiation oncologist, at The Ottawa Hospital and the University of Ottawa. Dr. Sheppard is a scientist at the Indigenous Cancer Care Unit, Cancer Care Ontario, Toronto, and assistant professor at the Dalla Lana School of Public Health, University of Toronto. Dr. Olson is a radiation oncologist, BC Cancer Centre for the North, Prince George, Canada. Dr. Brundage is a radiation oncologist at the Cancer Research Institute at Queen’s University, Kingston, Canada. Dr. Slotman is a radiation oncologist at the Amsterdam UMC – Vrije University Medical Center. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. Prior presentations: Chan J, Polo A, Abdel-Wahab M, Hirata D, Bourque JM, Zubizarreta E. Access to radiotherapy among indigenous populations in Canada. Poster presented at: 1) American Society for Radiation Oncology Annual Meeting; Oct. 21-24, 2018; San Antonio, Texas. 2) Canadian Association of Radiation Oncology Annual Meeting; Sept. 12-15, 2018; Montreal, Canada. 3) Toronto Global Cancer Control Conference; March 1-3, 2018; Toronto, Canada.
Dr. Yarney, Dr. Ayettey Anie, Dr. Vanderpuye, Dr. Asamoah, Dr. Awuah, Dr. Tagoe, Mr. Denyo, Dr. Scott, Dr. Doughan, Dr. Kyei, and Dr. Aidoo are with the National Radiotherapy Oncology and Nuclear Medicine Center, Korle Bu Teaching Hospital, Ghana. Dr. Edusais at Sweden Ghana Medical Center. Dr. Dwobeng is at the National Center for Radiotherapy and Nuclear Medicine, Komfo Anokye Teaching Hospital, Ghana. Dr. Wong and Dr. Vulpe are at Princess Margaret Hospital, Toronto, Canada. Dr. Awasthi, Ms. Fink, Dr. Wasserman, Dr. Johnstone, Dr. Harrison, and Dr. Yamoah are at H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, FL. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.
Prepared by Dr. Vargo and Dr. Beriwal while at the Magee Women’s Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA.